Novel tetrahydrocarbazole benzyl pyridine hybrids as potent and selective butryl cholinesterase inhibitors with neuroprotective and β-secretase inhibition activities

被引:28
作者
Ghobadian, Roshanak [1 ]
Mahdavi, Mohammad [2 ]
Nadri, Hamid [3 ,4 ]
Moradi, Alireza [3 ,4 ]
Edraki, Najmeh [5 ]
Akbarzadeh, Tahmineh [1 ,6 ]
Sharifzadeh, Mohammad [7 ]
Bukhari, Syed Nasir Abbas [8 ]
Amini, Mohsen [1 ]
机构
[1] Univ Tehran Med Sci, Dept Med Chem, Fac Pharm, Tehran 14176, Iran
[2] Univ Tehran Med Sci, Endocrinol & Metab Res Ctr, Endocrinol & Metab Clin Sci Inst, Tehran, Iran
[3] Shahid Sadoughi Univ Med Sci, Pharmaceut Sci Res Ctr, Yazd 8915173143, Iran
[4] Shahid Sadoughi Univ Med Sci, Fac Pharm, Yazd 8915173143, Iran
[5] Shiraz Univ Med Sci, Med & Nat Prod Chem Res Ctr, Shiraz, Iran
[6] Univ Tehran Med Sci, Persian Med & Pharm Res Ctr, Tehran, Iran
[7] Univ Tehran Med Sci, Dept Pharmacol & Toxicol, Fac Pharm, Tehran, Iran
[8] Jouf Univ, Dept Pharmaceut Chem, Coll Pharm, Al Jouf 2014, Sakaka, Saudi Arabia
关键词
Alzheimer's disease; Butyrylcholinesterase; Docking study; 2,3,4,9-Tetrahydro-1H-carbazole; In-vitro assay; SITE ACETYLCHOLINESTERASE INHIBITORS; ALZHEIMERS-DISEASE; BIOLOGICAL EVALUATION; BUTYRYLCHOLINESTERASE INHIBITORS; DRUG CANDIDATES; IN-VITRO; DERIVATIVES; DESIGN; MOIETY; DOCKING;
D O I
10.1016/j.ejmech.2018.05.031
中图分类号
R914 [药物化学];
学科分类号
100705 [微生物与生化药学];
摘要
Butyrylcholinesterase (BuChE) inhibitors have become interesting target for treatment of Alzheimer's disease (AD). A series of dual binding site BuChE inhibitors were designed and synthesized based on 2,3,4,9-tetrahydro-1H-carbazole attached benzyl pyridine moieties. In-vitro assay revealed that all of the designed compounds were selective and potent BuChE inhibitors. The most potent BuChE inhibitor was compound 6i (IC50 = 0.088 +/- 0.0009 mu M) with the mixed-type inhibition. Docking study revealed that 6i is a dual binding site BuChE inhibitor. Also, Pharmacokinetic properties for 6i were accurate to Lipinski's rule. In addition, compound 6i demonstrated neuroprotective and beta-secretase (BACE1) inhibition activities. This compound could also inhibit AChE-induced and self-induced A beta peptide aggregation at concentration of 100 mu M and 10 mu M respectively. Generally, the results are presented as new potent selective BuChE inhibitors with a therapeutic potential for the treatment of AD. (C) 2018 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:49 / 60
页数:12
相关论文
共 39 条
[1]
9H-Carbazole Derivatives Containing the N-Benzyl-1,2,3-triazole Moiety as New Acetylcholinesterase Inhibitors [J].
Akrami, Hamidreza ;
Mirjalili, Bibi F. ;
Khoobi, Mehdi ;
Moradi, Alireza ;
Nadri, Hamid ;
Emami, Saeed ;
Foroumadi, Alireza ;
Vosooghi, Mohsen ;
Shafiee, Abbas .
ARCHIV DER PHARMAZIE, 2015, 348 (05) :366-374
[2]
Novel coumarin derivatives bearing N-benzyl pyridinium moiety: Potent and dual binding site acetylcholinesterase inhibitors [J].
Alipour, Masoumeh ;
Khoobi, Mehdi ;
Foroumadi, Alireza ;
Nadri, Hamid ;
Moradi, Alireza ;
Sakhteman, Amirhossein ;
Ghandi, Mehdi ;
Shafiee, Abbas .
BIOORGANIC & MEDICINAL CHEMISTRY, 2012, 20 (24) :7214-7222
[3]
Donepezil-tacrine hybrid related derivatives as new dual binding site inhibitors of AChE [J].
Alonso, D ;
Dorronsoro, I ;
Rubio, L ;
Muñoz, P ;
García-Palomero, E ;
Del Monte, M ;
Bidon-Chanal, A ;
Orozco, M ;
Luque, FJ ;
Castro, A ;
Medina, M ;
Martínez, A .
BIOORGANIC & MEDICINAL CHEMISTRY, 2005, 13 (24) :6588-6597
[4]
Synthesis and Evaluation of Chroman-4-One Linked to N-Benzyl Pyridinium Derivatives as New Acetylcholinesterase Inhibitors [J].
Arab, Saman ;
Sadat-Ebrahimi, Seyed-Esmail ;
Mohammadi-Khanaposhtani, Maryam ;
Moradi, Alireza ;
Nadri, Hamid ;
Mahdavi, Mohammad ;
Moghimi, Setareh ;
Asadi, Mehdi ;
Firoozpour, Loghman ;
Pirali-Hamedani, Morteza ;
Shafiee, Abbas ;
Foroumadi, Alireza .
ARCHIV DER PHARMAZIE, 2015, 348 (09) :643-649
[5]
Benzofuran-derived benzylpyridinium bromides as potent acetylcholinesterase inhibitors [J].
Baharloo, Farzaneh ;
Moslemin, Mohammad Hossein ;
Nadri, Hamid ;
Asadipour, Ali ;
Mahdavi, Mohammad ;
Emami, Saeed ;
Firoozpour, Loghman ;
Mohebat, Razieh ;
Shafiee, Abbas ;
Foroumadi, Alireza .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2015, 93 :196-201
[6]
Insight into the kinetic of amyloid β(1-42) peptide self-aggregation:: Elucidation of inhibitors' mechanism of action [J].
Bartolini, Manuela ;
Bertucci, Carlo ;
Bolognesi, Maria Laura ;
Cavalli, Andrea ;
Melchiorre, Carlo ;
Andrisano, Vincenza .
CHEMBIOCHEM, 2007, 8 (17) :2152-2161
[7]
Forecasting the global burden of Alzheimer's disease [J].
Brookmeyer, Ron ;
Johnson, Elizabeth ;
Ziegler-Graham, Kathryn ;
Arrighi, H. Michael .
ALZHEIMERS & DEMENTIA, 2007, 3 (03) :186-191
[8]
Discovery, Biological Evaluation, and Crystal Structure of a Novel Nanomolar Selective Butyrylcholinesterase Inhibitor [J].
Brus, Boris ;
Kosak, Urban ;
Turk, Samo ;
Pislar, Anja ;
Coquelle, Nicolas ;
Kos, Janko ;
Stojan, Jure ;
Colletier, Jacques-Philippe ;
Gobec, Stanislav .
JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (19) :8167-8179
[9]
Tacrine-based dual binding site acetylcholinesterase inhibitors as potential disease-modifying anti-Alzheimer drug candidates [J].
Camps, Pelayo ;
Formosa, Xavier ;
Galdeano, Caries ;
Gomez, Tania ;
Munoz-Torrero, Diego ;
Ramirez, Lorena ;
Viayna, Elisabet ;
Gomez, Elena ;
Isambert, Nicolas ;
Lavilla, Rodolfo ;
Badia, Albert ;
Victoria Clos, M. ;
Bartolini, Manuela ;
Mancini, Francesca ;
Andrisano, Vincenza ;
Bidon-Chanal, Axel ;
Huertas, Oscar ;
Dafni, Thomai ;
Javier Luque, F. .
CHEMICO-BIOLOGICAL INTERACTIONS, 2010, 187 (1-3) :411-415
[10]
Probing the mid-gorge of cholinesterases with spacer-modified bivalent quinazolinimines leads to highly potent and selective butyrylcholinesterase inhibitors [J].
Chen, Xinyu ;
Tikhonova, Irina G. ;
Decker, Michael .
BIOORGANIC & MEDICINAL CHEMISTRY, 2011, 19 (03) :1222-1235